REXAHN PHARMACEUTICALS 10-Q 9-30-2011

Company

Opus Genetics, Inc.

Filed

November 9, 2011

Period of Report

September 30, 2011

Accession Number

0001140361-11-052700

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →